{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-044363","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2024-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.465572+00:00","generated_at":"2026-05-30T09:38:25.893443+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Acasti Pharma changes name to Grace Therapeutics; Nasdaq ticker becomes GRCE","bullets":["Name changed from Acasti Pharma Inc. to Grace Therapeutics, Inc., effective Oct 28, 2024.","Nasdaq ticker symbol changed from ACST to GRCE on October 28, 2024.","CUSIP number unchanged at 00439U104; no effect on shareholder rights.","Bylaws amended only to reflect new corporate name; no other changes made."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-044363","json":"https://secwatch.observer/filing/0001140361-24-044363.json","markdown":"https://secwatch.observer/filing/0001140361-24-044363.md","text":"https://secwatch.observer/filing/0001140361-24-044363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/0001140361-24-044363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036124044363/ef20037633_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:38:25.893443+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}